Serum Levels of Semaphorin 4C in Breast Cancer – Assessment of Prognostic Value and Potential for Monitoring Surgical Treatment Response
Introduction. The global burden of breast cancer (BC) has encouraged ceaseless research in exploring novel biomarkers, aiming to optimize BC management and prognosis.
Saved in:
| Main Authors: | Popov Ts., Maslyankov S., Arabadzhiev A., Sokolov M., Kandilarova S. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2024-12-01
|
| Series: | Acta Medica Bulgarica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/amb-2024-0070 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Immune Semaphorins in Sepsis—A Prospective Cohort Study
by: Branimir Gjurasin, et al.
Published: (2024-12-01) -
Role of the serum levels of the inter-organs messenger fibroblast growth factor 21 (FGF21) in the diagnosis and prognosis of breast cancer patients
by: Stella Maris Ranuncolo, et al.
Published: (2025-01-01) -
Towards the Identification of New Biomarkers in Saliva and Serum for Treatment Monitoring of Equine Gastric Ulcer Syndrome: A Liquid Proteomic Approach
by: Alberto Muñoz-Prieto, et al.
Published: (2024-10-01) -
An exploratory study of serum creatine kinase as a prognostic marker for patients with resectable pancreatic cancer: looking into the relationship with body composition
by: Cong Chen, et al.
Published: (2025-02-01) -
Multiplexed immunoassay for a serum autoantibody biomarker panel in diagnostic and prognostic prediction of canine mammary tumors
by: Chih-Ching Wu, et al.
Published: (2025-12-01)